ClinicalTrials.gg
RecruitingNCT06981351MCTUpdated Aug 17, 2026

Matching Treatments to Cognitive Deficits in Offenders With Substance Use Disorders

An interventional study of Attention to Context (ATC) training and Affective Cognitive Control (ACC) training in Antisocial Behavior, sponsored by The Mind Research Network. Recruiting at 1 site in United States. Open to male participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-08-17.

Sponsored by The Mind Research Network · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Mar 2025; still recruiting 1 year 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
288
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 26 studies in Antisocial Personality Disorder with a site in United States — 4 open to participants now, 6 under way, none of them phase 3. Antisocial Personality Disorder · United States.

Planned enrollment
5th of 18
288 · median 188
Started
2025
the only one that year
No phase
13 of 26
4 open now
Registered
25th of 26
by date

Among the 26 studies in Antisocial Personality Disorder with a site in United States, this one is the 5th largest by planned enrollment of the 18 interventional ones that give a count, is the only one that started in 2025, is one of 13 with no phase, and was the 25th registered.

Antisocial Personality Disorder

67 studies on the registry are indexed under Antisocial Personality Disorder; 10 are open to participants now.

Browse Antisocial Personality Disorder studies →

Open to participants now

4 of the 26 studies in Antisocial Personality Disorder with a site in United States are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 9 Antisocial Personality Disorder studies recruiting now, none set no upper age limit and 8 stop at 75 or younger; 1 takes children under 18; 1 takes healthy volunteers.

This study: 18 Years to 55 Years · male · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies in Antisocial Personality Disorder with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to investigate the effect of two types of cognitive remediation training on real-world behavioral outcomes including substance use, institutional adjustment, and recidivism following release from prison. Each training type is designed to target one of two subtypes of antisocial criminal offenders, who are characterized by either: 1) Attention to context-based deficits, or 2) Affective cognitive control-based deficits.

The main questions it aims to answer are:

Does matching deficit type with targeted cognitive training improve outcomes (relative to mismatched training)? What are the functional brain mechanisms that underlie treatment change?

Participants will:

Be assigned to cognitive training that either does or does not match their deficit type.

Complete six one-hour sessions of cognitive skills training. Complete pre and post-training behavioral tasks assessing self-regulation deficits.

Complete structural MRI scans and functional MRI scans assessing cognitive control.

Complete post-treatment follow-up assessments evaluating self-regulation, adjustment, and stressful life events, substance use and recidivism.

Read the detailed description

Prior research has identified two subtypes of antisocial offenders, typified by distinct dysfunctional cognitive emotion interactions undermining self-regulation. One subtype is characterized by an attention-based abnormality, which impairs adaptive processing of contextual information, tangential to one's primary focus. This abnormality is typified by offenders with high levels of callous/unemotional traits. A second subtype is characterized by hyper-reactions to personally relevant cues, interfering with executive functions that are otherwise needed to regulate behavior. This abnormality is prevalent in those with high externalizing characteristics. The investigators have developed cognitive skills training that addresses each of these specific deficits in distinct ways. These distinct interventions are intended to address mechanism-specific cognitive emotional dysfunction, as opposed to treating distinct dysfunctions with a uniform approach. The investigators' NIH-funded pilot work has shown evidence of improving outcomes in offenders by matching specific deficits with focused skills training. This project will execute a well-powered, randomized clinical trial to demonstrate reliability and generalizability of these effects. We expect to verify prior findings of improved outcomes by matching individual deficits with the targeted interventions. Effects of treatment on specific cognitive skills (assessed by laboratory-based tests) and real-world behavioral outcomes including substance use behaviors, institutional adjustment, and recidivism following release from prison will be examined. Further, advanced neuroimaging measures will be used to assess brain changes with treatment. This will aid in specifying potentially different mechanisms of treatment success in each respective group. This project addresses the ongoing need to improve and validate focused interventions that target specific deficits, replacing less-effective one-size-fits-all approaches.

03

Conditions studied

  • Antisocial Behavior

Keywords

  • Cognitive skills training
  • Attention to Context
  • Affective Cognitive Control
04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Currently incarcerated
  • No uncorrectable auditory or visual deficits
  • Able to speak and/or understand English
  • 5th grade reading level or higher
  • IQ score = 80 or above
  • Lifetime history of substance use disorder based on DSM criteria
  • No history of dementia or other cognitive disability
  • No indication of current psychotic disorder
  • No major medical illness or CNS disease
  • Scores from the Psychopathy Checklist-Revised (PCL-R) meet criteria for one of the designated treatment groups

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
288 participants (estimated)

Study arms

  • Experimental
    Attention to context deficit

    Participants with attention to context deficits will receive treatment either targeted towards their specific deficit (matched) or towards affective cognitive control deficits (mismatched).

    Behavioral: Attention to Context (ATC) training · Behavioral: Affective Cognitive Control (ACC) training

  • Experimental
    Affective Cognitive Control deficit

    Participants with affective cognitive control deficits will receive treatment either targeted towards their specific deficit (matched) or towards attention to context deficits (mismatched).

    Behavioral: Attention to Context (ATC) training · Behavioral: Affective Cognitive Control (ACC) training

  • Experimental
    No psychopathology

    Participants in the no psychopathology group will receive one of the two treatment types (ATC or ACC).

    Behavioral: Attention to Context (ATC) training · Behavioral: Affective Cognitive Control (ACC) training

Interventions

  • BehavioralAttention to Context (ATC) training

    ATC training focuses on learning to attend to and integrate contextual cues present in the environment. Three tasks, Reversal Learning, Divided Visual Field, and Affective Gaze, require ATC functioning and provide individuals with practice noticing changes in contextual information, such as rule changes and using emotion information to modulate behavior.

  • BehavioralAffective Cognitive Control (ACC) training

    ACC training focuses on providing individuals with practice inhibiting behavior, particularly within motivational or affective contexts. Three tasks, Shapes, Numbers, and Lottery, tap ACC functioning and place demands on the basic employment of cognitive control, such as task switching, as well as on the concurrent engagement of cognitive control and affective processing.

06

What researchers measure

Primary outcomes

  1. Cognitive task performance - Stroop

    Stroop task. Performance is quantified by number of correct responses (0 - 100)%.

    Time frame: From enrollment to end of treatment at six weeks

  2. Cognitive task performance - Lexical Decision Making

    Lexical Decision Making task. Performance is quantified by number of correct responses (0 - 100%).

    Time frame: From enrollment to end of treatment at six weeks

  3. Cognitive task performance - Delay Discounting

    Delay Discounting task. Performance is quantified quantified by calculating where the answers place the respondent amid reference discounting curves. Range 0.0-0.5.

    Time frame: From enrollment to end of treatment at six weeks

  4. Functional MRI - Go/NoGo task performance

    Functional MRI task performance (Go/NoGo task). Performance is quantified by the number of 'false alarms' (responding to the NoGo stimulus). Range 0-39.

    Time frame: Change assessed from enrollment to end of treatment at six weeks

  5. Functional MRI - Go/Nogo brain response

    Change (i.e. increased or decreased) in functional brain response (Blood Oxygen Level Dependent/BOLD) in region of interest (anterior cingulate) assessed using Statistical Parametric Mapping (SPM).

    Time frame: Activity assessed during MRI scan. Change assessed from enrollment to end of treatment at six weeks

  6. Real-World Outcomes - Substance use (TLFB)

    Substance use. Assessed using the timeline follow back (TLFB) - calendar recording dates of use for stimulant drugs.

    Time frame: From enrollment to six months post-release from incarceration

  7. Real-World Outcomes - Substance use (ASE)

    Substance use. Assessed using the Abstinence Self Efficacy scale (higher scores indicate greater difficulty with abstinence). Range 0-4.

    Time frame: From enrollment to six months post-release from incarceration

  8. Real-World Outcomes - Substance use (DUDIT)

    Substance use. Assessed using the Drug Use Disorders Identification test (higher scores indicate more/severe substance use). Range 0-44.

    Time frame: From enrollment to six months post-release from incarceration

  9. Real-World Outcomes - Criminal behavior

    Criminal behavior. Assessed using the Crime Inventory - records the number of instances of criminal behavior

    Time frame: From enrollment to six months post-release from incarceration

  10. Risky Impulsive Self-Destructive Behavior

    The RISQ questionnaire measures risky, impulsive, and self-destructive behaviors in 8 domains (aggression, self-harm, gambling, impulsive spending/driving, impulsive eating, risky sex, illegal behavior, and alcohol use). For each behavior, respondents note the number of times they have engaged in the behavior in their lifetime. Higher scores indicate more severe risky, impulsive, and self destructive behavior.

    Time frame: From enrollment to six months post-release from incarceration

07

Study locations

1 of 1 sites recruiting
  • Mind Research Network/Lovelace Biomedical Research Institute
    Albuquerque, New Mexico 87106, United States
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2025 (actual). Primary completion is estimated for May 2029, 50 months after the start.

Of 25 interventional studies with no phase under Antisocial Personality Disorder, half reached primary completion within 53 months of starting (the median), counting those still running; a quarter within 29 and three quarters within 66. This study's planned 50 months is close to that.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 24, 2025
First posted
May 20, 2025
StartActual
Mar 18, 2025
Primary completionEst.
May 31, 2029
CompletionEst.
May 31, 2029
Last update
Aug 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06981351
Lead sponsor
The Mind Research Network
Responsible party
Sponsor
First posted
May 20, 2025
Start date
Mar 18, 2025
Primary completion
May 31, 2029 (estimated)
Completion
May 31, 2029 (estimated)
Last update
Aug 17, 2026

Study contacts

Carla Harenski
Contact
charenski@mrn.org
505-272-5028

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion